{
  "id": "breast-cancer-cdk46-by-payer",
  "display_name": "ER+/HER2- MBC (By Payer)",
  "cohort": "ER+/HER2- MBC, 2L, by Payer Type (2024–2025)",
  "insight_type": "Payer Mix Opportunity",
  "summary": "Commercial patients have a 72% CDK4/6i utilization rate, while Medicare patients lag at 38%. Closing the Medicare gap could yield $120,000/year.",
  "chart": {
    "type": "bar",
    "unit": "payer",
    "data": [
      { "name": "Commercial", "value": 72, "gap": 7, "highlight": false },
      { "name": "Medicare", "value": 38, "gap": -27, "highlight": true },
      { "name": "Medicaid", "value": 55, "gap": -10, "highlight": false }
    ],
    "benchmark": 65,
    "nccn_target": 65
  },
  "financial_impact": {
    "annual_opportunity": "$120,000/year",
    "math": "$120,000/year = 32 Medicare patients × $3,750 margin per patient"
  },
  "clinical_impact": {
    "description": "Improving Medicare utilization increases survival.",
    "quantitative": "+8.7 months PFS"
  },
  "peer_comparison": {
    "description": "Top-performing oncology practices achieve 68% Medicare CDK4/6i utilization through streamlined authorization processes and patient support. Your Medicare rate of 38% is 30% below these leaders. Closing this gap could yield $168,750/year.",
    "peer_benchmark": 68,
    "financial_impact": {
      "annual_opportunity": "$168,750/year",
      "math": "$168,750/year = 45 Medicare patients × $3,750 margin per patient"
    },
    "action_steps": [
      "Implement peer-developed Medicare authorization toolkit for CDK4/6i",
      "Establish patient financial navigator program for Medicare patients",
      "Create Medicare Advantage plan-specific pathways based on peer best practices",
      "Develop standardized Medicare patient communication protocol"
    ]
  },
  "weighted_score": 88,
  "action_steps": [
    "Identify Medicare patients eligible for CDK4/6i",
    "Connect Medicare patients to financial assistance programs",
    "Review payer-specific barriers with care team"
  ],
  "suggestions": [
    "Negotiate with Medicare Advantage plans for better coverage"
  ],
  "drilldowns": [
    {
      "label": "Compare Sites",
      "cohort": "ER+/HER2- MBC, 2L, Medicare, by Site",
      "jsonFile": "breast-cancer-cdk46-medicare-by-site.json",
      "drilldownLevel": 2
    },
    {
      "label": "Variance by Regimen",
      "cohort": "ER+/HER2- MBC, 2L, Medicare, by Regimen",
      "jsonFile": "breast-cancer-cdk46-medicare-by-regimen.json",
      "drilldownLevel": 2
    }
  ]
} 